Found 80 with Last Name = 'vargiu' and Initial = 'l' TargetGag-Pol polyprotein [588-1027]/[588-1147](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: 25nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1027]/[588-1147](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: 31nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1027]/[588-1147](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: 33nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
3D Structure (crystal)TargetGag-Pol polyprotein [588-1027]/[588-1147](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: 72nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: 85nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: 110nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: 130nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1127,Y768C]/[588-1147,Y768C](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: 160nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Activity of selected HIV-1 N-acylthiocarbamates in enzyme assay against Virion-Associated reverse transcriptaseMore data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+3nMAssay Description:Activity of selected HIV-1 N-acylthiocarbamates in enzyme assay against Virion-Associated reverse transcriptaseMore data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:Activity of selected HIV-1 N-acylthiocarbamates in enzyme assay against Virion-Associated reverse transcriptaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1027]/[588-1147](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: 2.80E+3nMpH: 7.9 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1027,K690N]/[588-1147,K690N](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: 3.40E+3nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
Affinity DataIC50: 4.20E+3nMAssay Description:Activity of selected HIV-1 N-acylthiocarbamates in enzyme assay against Virion-Associated reverse transcriptaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1027,K690N]/[588-1147,K690N](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: >5.00E+3nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1027,K690N]/[588-1147,K690N](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: >5.00E+3nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1027,K690N]/[588-1147,K690N](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: >5.00E+3nMpH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+3nMAssay Description:Activity of selected HIV-1 N-acylthiocarbamates in enzyme assay against Virion-Associated reverse transcriptaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [588-1027]/[588-1147](Human immunodeficiency virus type 1)
Sapienza University of Rome
Sapienza University of Rome
Affinity DataIC50: 5.05E+4nMpH: 7.9 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
Affinity DataEC50: 400nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 100nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 30nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: >2.00E+5nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 4.20E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 2.00E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 6.00E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 3.60E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 1.10E+4nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 1.10E+4nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 6.00E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: >3.83E+4nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 9.90E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 6.00E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 1.10E+4nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 20nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 400nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 5.80E+4nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 380nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 1.00E+4nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 6.00E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 9.60E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 7.60E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 8nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 3.50E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 1.20E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 1.03E+4nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 25nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 8.80E+3nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: 35nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
Affinity DataEC50: >4.40E+4nMAssay Description:Concentration required to achieve 50% protection of MT-4 cell from the HIV-1 induced cytopathogenicity was determined by the MTT methodMore data for this Ligand-Target Pair
